903
Views
35
CrossRef citations to date
0
Altmetric
Review

Pulmonary fibrosis: a disease of alveolar collapse and collagen deposition

, , , &
Pages 615-619 | Received 17 Feb 2019, Accepted 21 May 2019, Published online: 05 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ling Wu, Li Pu & Zhifang Zhuang. (2023) miR-155-5p/FOXO3a promotes pulmonary fibrosis in rats by mediating NLRP3 inflammasome activation. Immunopharmacology and Immunotoxicology 45:3, pages 257-267.
Read now

Articles from other publishers (34)

Xiaotong Wang, Di Zhang, Yaxue Zhu, Daojie Li, Long Shen, Qiankun Wang, Yun Gao, Xiaoping Li & Mei Yu. (2024) Protein lysine acetylation played an important role in NH3-induced AEC2 damage and pulmonary fibrosis in piglets. Science of The Total Environment 908, pages 168303.
Crossref
Zhilin Luo, Liyuan Ji, Hongting Liu, Yao Sun, Conglu Zhao, Xiang Xu, Xiaoting Gu, Xiaoyu Ai & Cheng Yang. (2023) Inhalation Lenalidomide-Loaded Liposome for Bleomycin-Induced Pulmonary Fibrosis Improvement. AAPS PharmSciTech 24:8.
Crossref
Md Meraj Anjum, Krishna Kumar Patel, Sankha Bhattacharya, Dilip Kumar Arya, Prashant Pandey, Vijayakumar MR, Sanjay Singh & Paruvathanahalli Siddalingam Rajinikanth. (2023) Overcoming barriers in cystic fibrosis therapy through inhalational lipid nanoparticles: Challenges and advances. Journal of Drug Delivery Science and Technology 89, pages 105068.
Crossref
Daniel E. Hurtado, Nibaldo Avilés-Rojas & Felipe Concha. (2023) Multiscale modeling of lung mechanics: From alveolar microstructure to pulmonary function. Journal of the Mechanics and Physics of Solids 179, pages 105364.
Crossref
Yang Miao, Yanhua Wang, Zhun Bi, Kai Huang, Jingjing Gao, Xiaohe Li, Shimeng Li, Luqing Wei, Honggang Zhou & Cheng Yang. (2023) Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice. BMC Pulmonary Medicine 23:1.
Crossref
Tong Feng, Ran Duan, Pengcheng Zheng, Jing Qiu, Qingyuan Li & Wancheng Li. (2023) Oxymatrine inhibits TGF‑β1‑mediated mitochondrial apoptotic signaling in alveolar epithelial cells via activation of PI3K/AKT signaling. Experimental and Therapeutic Medicine 25:5.
Crossref
Jiansheng Li, Kangchen Li, Yange Tian, Peng Zhao, Xuefang Liu, Minyan Li & Yunping Bai. (2023) Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling. Phytomedicine 109, pages 154604.
Crossref
Yi Liu, Demin Cheng, Yue Wang, Sichuan Xi, Ting Wang, Wenqing Sun, Guanru Li, Dongyu Ma, Siyun Zhou, Ziwei Li & Chunhui Ni. (2022) UHRF1-mediated ferroptosis promotes pulmonary fibrosis via epigenetic repression of GPX4 and FSP1 genes. Cell Death & Disease 13:12.
Crossref
Jade Jaffar, Mae Wong, Gregory A. Fishbein, Monther Alhamdoosh, Laura McMillan, Cristina Gamell-Fulla, Milica Ng, Nick Wilson, Karen Symons, Ian Glaspole & Glen Westall. (2022) Matrix metalloproteinase-7 is increased in lung bases but not apices in idiopathic pulmonary fibrosis. ERJ Open Research 8:4, pages 00191-2022.
Crossref
Kena Song, Zhangqing Yu, Xiangyang Zu, Guoqiang Li, Zhigang Hu & Yun Xue. (2022) Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment. International Journal of Molecular Sciences 23:18, pages 10509.
Crossref
Li Liu, Wei Song, Jing Zeng & Zhihong Peng. (2022) Evaluating a Specific Dual ROCK Inhibitor against Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats. ACS Pharmacology & Translational Science 5:9, pages 819-828.
Crossref
Rui Wang, Jian Xu, Rong Yan, Huanbin Liu, Jingxin Zhao, Yuan Xie, Wenbin Deng, Weiping Liao & Yichu Nie. (2022) Virtual screening and activity evaluation of multitargeting inhibitors for idiopathic pulmonary fibrosis. Frontiers in Pharmacology 13.
Crossref
Thalles de Freitas Castro, Natália Alves de Matos, Ana Beatriz Farias de Souza, Guilherme de Paula Costa, Luiza Oliveira Perucci, André Talvani, Sílvia Dantas Cangussú, Rodrigo Cunha Alvim de Menezes & Frank Silva Bezerra. (2022) Protein restriction during pregnancy affects lung development and promotes oxidative stress and inflammation in C57 BL/6 mice offspring. Nutrition 101, pages 111682.
Crossref
Tomasz Wybranowski, Jerzy Pyskir, Maciej Bosek, Marta Napiórkowska, Michał Cyrankiewicz, Blanka Ziomkowska, Marta Pilaczyńska-Cemel, Małgorzata Pyskir, Milena Rogańska, Stefan Kruszewski & Grzegorz Przybylski. (2022) The Mortality Risk and Pulmonary Fibrosis Investigated by Time-Resolved Fluorescence Spectroscopy from Plasma in COVID-19 Patients. Journal of Clinical Medicine 11:17, pages 5081.
Crossref
Hongbo Ma, Xuyi Wu, Yi Li & Yong Xia. (2022) Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis. Frontiers in Pharmacology 13.
Crossref
Belinda Dsouza, Kathleen M. Capaccione, Aron Soleiman, Jay Leb & Mary Salvatore. (2022) COVID-19 on Chest CT: Translating Known Microscopic Findings to Imaging Observations. Life 12:6, pages 855.
Crossref
Peng Lu, Jiawei Li, Chuanxin Liu, Jian Yang, Hui Peng, Zhifeng Xue & Zhidong Liu. (2022) Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis. Asian Journal of Pharmaceutical Sciences 17:3, pages 447-461.
Crossref
Hongbo Ma, Xuyi Wu, Yi Li & Yong Xia. (2022) Avances en la investigación de los mecanismos moleculares, los blancos terapéuticos y el desarrollo de fármacos para la fibrosis pulmonar idiopática. Kompass Neumología 4:3, pages 129-146.
Crossref
Caroline Busatta Vaz de Paula, Seigo Nagashima, Vanessa Liberalesso, Mariana Collete, Felipe Paes Gomes da Silva, Alessandro Gonçalves Gomes Oricil, Giovanna Silva Barbosa, Guilherme Vieira Cavalcante da Silva, David Batista Wiedmer, Felipe da Silva Dezidério & Lucia Noronha. (2021) COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis. International Journal of Molecular Sciences 23:1, pages 168.
Crossref
Miriana d’Alessandro, Laura Bergantini, Elena Bargagli & Silvia Vidal. (2021) Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review. Life 11:12, pages 1401.
Crossref
Nikos K. Karamanos, Achilleas D. Theocharis, Zoi Piperigkou, Dimitra Manou, Alberto Passi, Spyros S. Skandalis, Demitrios H. Vynios, Véronique Orian‐Rousseau, Sylvie Ricard‐Blum, Christian E.H. Schmelzer, Laurent Duca, Madeleine Durbeej, Nikolaos A. Afratis, Linda Troeberg, Marco Franchi, Valentina Masola & Maurizio Onisto. (2021) A guide to the composition and functions of the extracellular matrix. The FEBS Journal 288:24, pages 6850-6912.
Crossref
Punithavathi Durairaj, Santosh Venkatesan, Venkatesan Narayanan & Mary Babu. (2021) Curcumin inhibition of bleomycin-induced changes in lung collagen synthesis, deposition and assembly. Molecular Biology Reports 48:12, pages 7775-7785.
Crossref
Zongwei Liu, Xiaofang Tang, Zongling Zhu, Xunxun Ma, Wenjuan Zhou & Weijiang Guan. (2021) Recent Advances in Fluorescence Imaging of Pulmonary Fibrosis in Animal Models. Frontiers in Molecular Biosciences 8.
Crossref
Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, Chiara Romei & Claudia Martini. (2021) Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients. Biochemical Pharmacology 193, pages 114812.
Crossref
Gang Liu, Ashleigh M. Philp, Tamera Corte, Mark A. Travis, Heidi Schilter, Nicole G. Hansbro, Chris J. Burns, Mathew S. Eapen, Sukhwinder S. Sohal, Janette K. Burgess & Philip M. Hansbro. (2021) Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacology & Therapeutics 225, pages 107839.
Crossref
Kathleen M. Capaccione, Aijin Wang, Shing M. Lee, Nina Patel, John H.M. Austin, Pamela Maino, Maria Padilla & Mary M. Salvatore. (2021) Quantifying normal lung in pulmonary fibrosis: CT analysis and correlation with %DLCO. Clinical Imaging 77, pages 287-290.
Crossref
Martina Sterclova, Amit Kishore, Katerina Sikorova, Jelena Skibova, Martin Petrek, Martina Vasakova & Martina Vasakova. (2021) Effect of genotype on the disease course in idiopathic pulmonary fibrosis despite antifibrotic treatment. Biomedical Reports 15:5.
Crossref
Xiaohe Li, Kai Huang, Xiaowei Liu, Hao Ruan, Ling Ma, Jingjing Liang, Yunyao Cui, Yanhua Wang, Shuyang Wu, Hailong Li, Yuli Wei, Zeping Li, Jingjing Gao, Bo Yang, Xiaoping Li, Guang Yang, Honggang Zhou & Cheng Yang. (2021) Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway. Frontiers in Pharmacology 12.
Crossref
Ruo-Fei Li, Xin-Yue Chen, Yong Xu, Fan-Chao Feng, Hai-Lang He & Xian-Mei Zhou. (2021) Inhibitory effects of alkaline extract from the pericarp of Citrus reticulata Blanco on collagen behavior in bleomycin-induced pulmonary fibrosis. Journal of Ethnopharmacology 269, pages 113761.
Crossref
Timothy N. Perkins & Tim D. Oury. (2021) The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?. Therapeutic Advances in Respiratory Disease 15, pages 175346662110160.
Crossref
Yu-Zhi Lu, Xin-Liang He, Fei Liu, Pei-Pei Cheng, Li-Mei Liang, Meng Wang, Shuai-Jun Chen, Yi Huang, Fan Yu, Jian-Bao Xin, Hong Ye, Lin-Jie Song & Wan-Li Ma. (2020) Bleomycin induced apical-basal polarity loss in alveolar epithelial cell contributes to experimental pulmonary fibrosis. Experimental Cell Research 396:1, pages 112295.
Crossref
Xionghua Sun, Xinjian Cui, Xihua Chen & Xiaogang Jiang. (2020) Baicalein alleviated TGF β1-induced type I collagen production in lung fibroblasts via downregulation of connective tissue growth factor. Biomedicine & Pharmacotherapy 131, pages 110744.
Crossref
Sun Chun-Bin, Ying Yi, Wu Qin-Yi, Liu Yang, Yu Jing-Ze, Xing Hai-Jing, Zhang Si-Qi, Hou Jiong, Wen Jing, Liu Fei-Yu, Yan Jin-Yuan, Yuan Jia-Li & Zhong-Shan Yang. (2020) The main active components of Curcuma zedoaria reduces collagen deposition in human lung fibroblast via autophagy. Molecular Immunology 124, pages 109-116.
Crossref
Kirsten Sehlmeyer, Jannik Ruwisch, Nuria Roldan & Elena Lopez-Rodriguez. (2020) Alveolar Dynamics and Beyond – The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis. Frontiers in Physiology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.